A Cleveland Clinic physician defines the elusive term
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/ee1a6dcd-3c3a-4afb-88aa-bc9dbc0491eb/Dr_Kalaycia_650x450_jpg)
Dr.Kalaycia_650x450
Matt Kalaycio, MD, Chair of the Department of Hematology and Medical Oncology at Cleveland Clinic, offers principles to help the healthcare industry enable high reliability at the system and individual level in his latest editorial in Hematology News. Dr. Kalaycio, Editor in Chief of the publication, describes the disconnect between physicians and administrators when defining and prioritizing high reliability.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
“When the Joint Commission on Accreditation of Healthcare Organizations came to our hospital for a survey last fall, our administration was confident that the review would be favorable. The Joint Commission was stressing the reliability of hospitals and so were we. We had chartered a “High-Reliability Organization Enterprise Steering Committee” that was “empowered to make recommendations to the (executive board) on what is needed to achieve the goals of high reliability across the enterprise.” High reliability was a priority for our administration and for the Joint Commission. Unfortunately, nearly no one else knew what high reliability meant.
When physicians think about reliability, we think about reproducibility and precision. What often is less clear, then, is what our administrators mean when they discuss the importance of “high reliability” in a hospital or health care system.”
Dr. Kalaycio offers five principles for organizations wanting to achieve high reliability, defined as reliable prevention or error, adapted from Managing the Unexpected: Resilient Performance in the Age of Uncertainty.
For individuals, Dr. Kalaycio argues that five similar principles, adapted from Unaccountable: What Hospitals Won’t Tell You and How Transparency Can Revolutionize Health Care, apply:
Advertisement
For more from Dr. Kalaycio on high reliability, read his editorial in Hematology News.
Advertisement
Advertisement
New guidelines empower clinicians with practical diagnostic framework
Pivotal Studies Guide Treatment Decisions in Muscle-Invasive Bladder Cancer
Reflections from an oncology provider and communications educator on new ASCO Guidelines on Patient-Clinician Communication
Phase 1 trial outcomes offer encouraging news for developing targeted therapy for solid tumors
Cleveland Clinic to administer first-of-its-kind T-cell therapy
Heavily pretreated patients experience improved progression-free survival and quality of life with CD20xCD3 therapy
Innovative procedure reduces scarring, recovery time and nipple sensation
Best practices for supporting patients with honesty and compassion